SAFE Biomedical Research Act

Hozzl · 2023-03-08T19:58:48Z

Explore the details of House Bill 5626 SAFE Biomedical Research Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

3/8/2023, 7:58 PM

Summary of Bill HR 5626

The SAFE Biomedical Research Act, also known as Bill 117 hr 5626, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to ensure the ethical treatment of animals used in biomedical research.

The bill outlines specific guidelines and regulations that research facilities must follow when conducting experiments on animals. These guidelines include requirements for proper housing, feeding, and medical care for the animals, as well as protocols for minimizing pain and distress during experiments.

Additionally, the SAFE Biomedical Research Act aims to promote transparency in research practices by requiring facilities to report detailed information about their animal testing procedures to the public. This includes information on the number and species of animals used, the purpose of the research, and the outcomes of the experiments. Overall, the SAFE Biomedical Research Act seeks to strike a balance between the important scientific advancements that can be made through animal research and the ethical treatment of animals involved in these experiments. It is currently being debated in Congress, with supporters arguing that it is necessary to protect animal welfare, while opponents raise concerns about potential impacts on scientific progress.

Congressional Summary of HR 5626

Securing And Fortifying Everyday Biomedical Research Act or the SAFE Biomedical Research Act

This bill requires the National Institutes of Health (NIH) to address national security concerns with respect to the biomedical research it conducts or supports.

Specifically, the NIH must consult with relevant agencies within the Department of Health and Human Services and other federal partners, including the Federal Bureau of Investigation, regarding research that may affect or be affected by matters of national security. The NIH must also ensure that recipients of its funding adhere to appropriate technology practices and policies to safeguard identifiable, sensitive information.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 5626

Bill HR 5626 is currently in the status of Bill Introduced since October 19, 2021. Bill HR 5626 was introduced during Congress 117 and was introduced to the House on October 19, 2021. Bill HR 5626's most recent activity was Referred to the Subcommittee on Health. as of October 20, 2021

Bipartisan Support of Bill HR 5626

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 5626

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 5626

SAFE Biomedical Research Act

Securing And Fortifying Everyday Biomedical Research Act

To amend title IV of the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to consult with certain heads of Federal agencies with respect to biomedical research that may affect national security, and for other purposes.